Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
about
The spongiform encephalopathies.Biosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth StudyCardiovascular disease and risk factors in adults with hypopituitarism.Transmission barriers for bovine, ovine, and human prions in transgenic mice.Prions and blood products.Effects of growth hormone and prolactin on hematopoiesis.Leucocyte depletion of the blood supply - how will patients benefit?Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases.Creutzfeldt-Jakob disease and the eye. I. Background and patient management.Current status review: cerebral amyloid.Etiology and pathogenesis of prion diseases.Growth hormone and tumour recurrenceTransmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.Attempts to restore scrapie prion infectivity after exposure to protein denaturantsPeak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review.Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system.How to tackle a possible Creutzfeldt-Jakob disease necropsySensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease.Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity.A further British case of growth hormone induced Creutzfeldt-Jakob disease.Creutzfeldt-Jakob disease and blood transfusion.Pituitary growth hormone and Creutzfeldt-Jakob disease.Creutzfeldt-Jakob disease and blood transfusion.Seeds of neuroendocrine doubt.Creutzfeldt-Jakob disease in Scotland and Northern Ireland 1980-1989.
P2860
Q33589743-5728FBCC-54DE-41FA-B6B4-132B642C6AEAQ33625052-F441DA74-A89F-466D-AD9A-958706F7669DQ33643486-9DCA67AC-EDA5-4376-A6EE-99E4970C7607Q33754930-42DE5BEE-97FD-4BEB-A3D5-1702D8FD94DCQ33925903-29FFD85E-0615-4BCA-9790-19599705AF22Q34011516-ABDF4DD5-73AC-4CA8-ADD2-549C5ABACEBAQ34022474-68C70017-CCEF-41C7-BF33-37379FD7DEFDQ34028842-3334D69B-32DB-4D0A-AC29-3028E52D2912Q34057654-EA2DEED1-F5C9-486D-AE01-F094070093E3Q35358564-24258514-3AF0-4C3D-A53C-A592339B9F55Q35795039-2888A8C4-44BD-400F-84F3-DB392AA41BA1Q35821424-1E49397F-6730-423D-B144-D79A0D9B4F58Q35823555-1353C47A-ECC7-47F2-BEC0-D6AF1510509FQ36200377-513949D6-3E13-4F75-ADC4-C02AF4502756Q36201241-8F04E352-57F2-417E-BEEC-11F8E4E864A3Q36688984-80427C3E-3D76-415F-BC63-E741A17E36AEQ37232746-8E1DAEE2-97A8-4AF7-9331-6BE3827FE2D8Q38025005-28AF6E70-710D-449C-BF41-09126FB726CDQ38205919-886CC700-F2B2-4F6C-B25C-AF5548805CCEQ39232976-E992E8D8-CA10-469A-8FFE-D52361DAC782Q43164228-45BF73E9-90E7-4F71-A745-6F6BE2D71090Q43164830-6C89C69E-8600-4F30-B860-22A660DB4183Q43540532-AA9DCEB3-334F-472A-AEEF-B5F824E44FDBQ48625398-AB3EC0C6-5140-46B4-B416-985F81B581FBQ50542375-8C30E5C1-3C22-449A-8E18-4AB4EAB0C2AC
P2860
Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@ast
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@en
type
label
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@ast
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@en
prefLabel
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@ast
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@en
P2093
P2860
P356
P1433
P1476
Mortality, neoplasia, and Creu ...... hormone in the United Kingdom.
@en
P2093
C R Buchanan
M A Preece
R D Milner
P2860
P304
P356
10.1136/BMJ.302.6780.824
P407
P577
1991-04-01T00:00:00Z